Description of the medicine: Teridecase (Terridecasum)

TERRIDECASUM.

Modified dosage form of terrylitin, obtained by its addition to polyglucin.

Porous mass or lyophilized powder of white (with a yellowish tinge) color.

Apply externally for the treatment of purulent wounds, pressure sores, trophic ulcers.

Intrapleural and intra-bronchial administration is prescribed for abscesses, bronchiectasis and other inflammatory diseases of the respiratory tract.

External applied in the form of a solution. The contents of the vial (100 PE-proteolytic units) are diluted in 2-5 ml of distilled water, or 0.9% solution of sodium chloride, or 0.25% solution of novocaine, moistened with a gauze cloth and applied to the affected area, and covered with a liquid-impermeable dressing. The bandage is changed 1 time in 1-2 days.

When empyema injected into the pleural cavity of turundas with a solution. When hemothorax injected intrapleural 100-200 PE (in 2-5 ml solution) 1 time per day for 2-7 days.

When purulent tracheobronchitis is injected through the intubation tube 100 PE (in 2-5 ml of solution) 5-6 times a day for 3-4 days.

When the sputum is delayed (after resection of the lungs) 10-15 PE are administered intratracheally (in 2-3 ml of the solution obtained by diluting 100 PE in 20 ml of 0.9% sodium chloride solution); For the course - 1-3 procedures.

Product: powder in hermetically sealed vials and ampoules of 100 PE.

Storage: List B. In a dry, dark place at a temperature of 0 to +10 ° C.